title: Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
authors.forename: L
authors.initials: L
authors.lastname: Del Mastro
authors.forename: M
authors.initials: M
authors.lastname: Venturini
authors.forename: M
authors.initials: M
authors.lastname: Costantini
authors.forename: O
authors.initials: O
authors.lastname: Garrone
authors.forename: M R
authors.initials: MR
authors.lastname: Sertoli
authors.forename: G
authors.initials: G
authors.lastname: Bertelli
authors.forename: A M
authors.initials: AM
authors.lastname: Machì
authors.forename: R
authors.initials: R
authors.lastname: Rosso
mesh_terms: D000740:Anemia / Q000209:etiology / Q000503:physiopathology*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D017086:beta-Thalassemia / Q000150:complications* / Q000503:physiopathology
chemical_list: D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil